Skip to content
2000
Volume 12, Issue 4
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Wiping out malaria is now the global concern as about three billion people are at risk of malaria infection globally. Despite of extensive research in the field of vaccine development for malaria, till now, no effective vaccine is available for use and hence only antimalarial drugs remain our best hope for both treatment and prevention of malaria. However, emergence and spread of drug resistance has been a major obstacle for the success of malaria elimination globally. This review will summarize the information related to antimalarial drugs, drug development strategies, drug delivery through nanoparticles, few current issues like adverse side effects of most antimalarial drugs, non availability of drugs in the market and use of fake/poor quality drugs that are hurdles to malaria control. As we don’t have any other option in the present scenario, we have to take care of the existing tools and make them available to almost all malaria affected area.

Loading

Article metrics loading...

/content/journals/cddt/10.2174/1570163812666150907100019
2015-12-01
2025-10-19
Loading full text...

Full text loading...

/content/journals/cddt/10.2174/1570163812666150907100019
Loading

  • Article Type:
    Research Article
Keyword(s): Antimalarial drug; development; resistance
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test